FITC Anti-CD24 抗体 [SN3]
FITC Anti-CD24 antibody [SN3]
5
(1 Review)
|
(20 Publications)
Mouse Monoclonal CD24 antibody - conjugated to FITC. Suitable for Flow Cyt and reacts with Human samples. Cited in 20 publications.
別名を表示する
CD24, CD24A, Signal transducer CD24, Small cell lung carcinoma cluster 4 antigen
- Flow Cyt
Unknown
Flow Cytometry - FITC Anti-CD24 antibody [SN3] (AB30350)
Staining of human peripheral blood granulocytes with SN3 mouse monoclonal anti-human CD24 FITC conjugated (ab30350)
関連する標識済み抗体及び組成の異なる製品 (6)
-
660 APC
APC Anti-CD24 antibody [SN3]
-
785 APC/Cy7®
APC/Cy7® Anti-CD24 antibody [SN3]
-
723 Alexa Fluor® 700
Alexa Fluor® 700 Anti-CD24 antibody [SN3]
-
578 PE
PE Anti-CD24 antibody [SN3]
-
578 PE
PE Anti-CD24 antibody [SN3]
-
695 PerCP/Cy5.5®
PerCP/Cy5.5® Anti-CD24 antibody [SN3]
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD24 functions like a molecular "switch" modulating signals sent between cells. It acts as a ligand for multiple receptors and participates in cellular communication especially influencing the immune system. Part of its biological role involves interaction within cellular complexes impacting immune modulation and inflammatory responses. CD24's location at the interface of cellular microenvironments makes it critical for cellular response adaptation to varied external stimuli.
Pathways
CD24 participates in both immune signaling and cancer-related pathways. It plays a significant role in the suppression of the immune response often interacting with proteins like Siglec-10 in these pathways. CD24's involvement in these pathways contributes to cell survival and proliferation particularly within cancer development. The protein’s interaction within specified signaling pathways allows it to influence downstream targets that regulate gene expression and cellular functions.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (20)
Recent publications for all applications. Explore the full list and refine your search
Journal of gastrointestinal oncology 14:1669-1693 PubMed37720449
2023
Applications
Unspecified application
Species
Unspecified reactive species
Immunomedicine 2: PubMed36816458
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:3896-3910 PubMed35109743
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34396431
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 141:111815 PubMed34130123
2021
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 10:10016-10030 PubMed32929331
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 55:1003-1018 PubMed31545416
2019
Applications
Unspecified application
Species
Unspecified reactive species
Behavioural brain research 365:48-55 PubMed30831140
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 16:5923-5929 PubMed30344742
2018
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 42:2193-2202 PubMed30015833
2018
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com